Clinical Trials Study
Copyright ©The Author(s) 2024.
World J Gastroenterol. Oct 14, 2024; 30(38): 4211-4220
Published online Oct 14, 2024. doi: 10.3748/wjg.v30.i38.4211
Table 2 Comparison of spectral-computed tomography histogram parameters and HER-2 status in gastric cancer
Parameters
HER-2 positive (n = 21)
HER-2 negative (n = 80)
P value
Min-2.000 (-5.518, 1.000)-0.500 (-7.750, 5.000)0.143
Max37.000 (29.500, 40.622)41.000 (36.000, 50.750)0.018
Mean17.429 (14.923, 19.341)21.176 (17.529, 25.899)0.001
Std4.383 (3.663, 4.949)5.037 (4.285, 5.883)0.015
Variance19.198 (13.417, 24.489)25.366 (18.359, 34.604)0.015
CV0.269 ± 0.0670.245 ± 0.0710.163
Skewness-0.051 (-0.246, 0.020)-0.064 (-0.289, 0.182) 0.569
Kurtosis0.282 (0.020, 0.683) 0.280 (0.037, 0.617) 0.861
Entropy2.843 ± 0.2563.012 ± 0.2590.009
1st percentile6.037 (3.500, 9.000) 9.000 (6.000, 12.75) 0.007
5th percentile10.000 (7.000, 12.000) 12.500 (10.000, 16.750) 0.003
10th percentile11.000 (9.000, 13.500) 14.000 (12.000, 18.750) 0.003
25th percentile14.086 (12.000, 16.500)17.000 (14.000, 21.750) 0.002
50th percentile18.000 (15.000, 19.500) 21.000 (18.000, 25.750) 0.001
75th percentile20.122 (18.000, 23.000) 24.000 (21.000, 30.500) 0.001
90th percentile24.000 (19.500, 26.000) 27.000 (24.000, 35.000) 0.001
95th percentile24.147 (21.000, 28.000) 29.000 (25.000, 37.750) 0.001
99th percentile28.171 (24.000, 30.500) 32.500 (28.000, 40.750) 0.001
Lesion volume14.643 (4.214, 41.820) 9.930 (4.418, 21.191) 0.266